DOI
https://doi.org/10.18849/ve.v9i1.680Abstract
PICO Question
In cats with chronic gingivostomatitis, does using intravenous mesenchymal stem cell therapy, compared to not using it, lead to the improvement of clinical signs?
Clinical bottom line
Category of research
Treatment.
Number and type of study designs reviewed
Five interventional studies (clinical trials).
Strength of evidence
Moderate.
Outcomes reported
The reviewed studies indicate intravenous mesenchymal stem cell (MSC) therapy is safe to administer and can be effective in remission or alleviating the clinical signs of refractory, chronic gingivostomatitis in cats that have undergone full-mouth tooth extraction.
Conclusion
The collective evidence supports the intravenous administration of mesenchymal stem cell (MSC) therapy in cats with chronic gingivostomatitis following dental extraction. However, conducted clinical trials are prone to different degrees of bias due to the lack of independent control groups, the small number of subjects, and enrolling subjects with various severity of the disease. Therefore, more robust evidence can be obtained through well-designed randomised controlled trials to confirm the observed positive effects of the treatment in cats with a broader range of characteristics.
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
References
Arzi, , Clark, K. C., Sundaram, A., Spriet, M., Verstraete, F. J. M., Walker, N. J., Loscar, M. R., Fazel, N., Murphy, W. J., Vapniarsky, N. & Borjesson, D. L. (2017). Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. Stem Cells Translational Medicine. 6(8), 1710–1722. DOI: https://doi.org/10.1002/sctm.17-0035
Arzi, , Mills-Ko, E., Verstraete, F. J. M., Kol, A., Walker, N. J., Badgley, M. R., Fazel, N., Murphy, W. J., Vapniarsky, N. & Borjesson, D. L. (2016). Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Translational Medicine. 5(1), 75–86. DOI: https://doi.org/10.5966/sctm.2015-0127
Arzi, , Peralta, S., Fiani, N., Vapniarsky, N., Taechangam, N., Delatorre, U., Clark, K. C., Walker, N. J., Loscar, M. R., Lommer, M. J., Fulton, A., Battig, J. & Borjesson, D. L. (2020). A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis. Stem Cell Research & Therapy. 11(1), 115. DOI: https://doi.org/10.1186/s13287-020-01623-9
Arzi, , Taechangam, N., Lommer, M. J., Walker, N. J., Loscar, M. R. & Borjesson, D. L. (2021). Stem cell therapy prior to full-mouth tooth extraction lacks substantial clinical efficacy in cats affected by chronic gingivostomatitis. Journal of Feline Medicine and Surgery. 23(6), 604–608. DOI: https://doi.org/10.1177/1098612X20967172
Bauer, G., Elsallab, M. & Abou-El-Enein, M. (2018). Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Stem Cells Translational Medicine. 7(9), 676–685. DOI: https://doi.org/10.1002/sctm.17-0282
Febre, , Saulnier, N., Roux, P., Boutoille, F., Girard, N., Robert, C., Rakic, R., Rosset, E. & Maddens, S. (2022). Placenta-derived mesenchymal stromal cells as a treatment for refractory chronic gingivostomatitis in cats: eight cases (2018). Journal of Small Animal Practice. 64(4), 296–305. DOI: https://doi.org/10.1111/jsap.13583
Hennet, P. R., Camy, G. A. L., McGahie, D. M. & Albouy, M. V. (2011). Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats (2011). Journal of Feline Medicine and Surgery. 13(8), 577–587. DOI: https://doi.org/10.1016/j.jfms.2011.05.012
Huňáková, K., Hluchý, M., Špaková, T., Matejová, J., Mudroňová, D., Kuricová, M., Rosocha, J. & Ledecký, V. (2020). Study of bilateral elbow joint osteoarthritis treatment using conditioned medium from allogeneic adipose tissue-derived MSCs in Labrador retrievers. Research in Veterinary Science. 132, 513–520. DOI: https://doi.org/10.1016/j.rvsc.2020.08.004
Inukai, T., Katagiri, W., Yoshimi, R., Osugi, M., Kawai, T., Hibi, H. & Ueda, M. (2013). Novel application of stem cell-derived factors for periodontal regeneration. Biochemical and Biophysical Research Communications. 430(2), 763–768. DOI: https://doi.org/10.1016/j.bbrc.2012.11.074
Jennings, M. W., Lewis, J. R., Soltero-Rivera, M. M., Brown, D. C. & Reiter, A. M. (2015). Effect of tooth extraction on stomatitis in cats: 95 cases (2000–2013). Journal of the American Veterinary Medical Association. 246(6), 654–660. DOI: https://doi.org/10.2460/javma.246.6.654
Lommer, M. J. (2013). Efficacy of Cyclosporine for Chronic, Refractory Stomatitis in Cats: A Randomized, Placebo-Controlled, Double-Blinded Clinical Study. Journal of Veterinary Dentistry, 30(1), 8–17. DOI: https://doi.org/10.1177/089875641303000101
Pérez-Merino, E. M., Usón-Casaús, J. M., Zaragoza-Bayle, C., Duque-Carrasco, J., Mariñas-Pardo, L., Hermida-Prieto, M., Barrera-Chacon, R. & Gualtieri, M. (2015). Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes. The Veterinary Journal, 206(3), 385–390. DOI: https://doi.org/10.1016/j.tvjl.2015.08.003
Soltero-Rivera, M., Hart. S., Blandino, A., Vapniarsky, N. & Arzi, B. (2023). Mesenchymal stromal cell therapy for feline chronic gingivostomatitis: Long term experience. Frontiers in Veterinary Science. 10:1171922. DOI: https://doi.org/10.3389/fvets.2023.1171922
Vidane, A. S., Pinheiro, A. O., Casals, J. B., Passarelli, D., Hage, M. C. F. N. S., Bueno, R. S., Martins, D. S., & Ambrósio, C. E. (2017). Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats. Reproduction in Domestic Animals, 52, 316-326. DOI: https://doi.org/10.1111/rda.12846
License
Copyright (c) 2024 Omid Nekouei, San Tung Wong, Tiffany Ka Yi Leung, Qi An Ngai, Wing Sum Wong, Angel Almendros
This work is licensed under a Creative Commons Attribution 4.0 International License.
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
Most read articles by the same author(s)
- Omid Nekouei, Sophie St-Hilaire, Pak Chun Hui, Karen Chan, Isabel Sumyi Chan, Sum Yuet Lorraine Ngan, Yion Chan, Ka Po Chung, Sunguk Hong, Hiu Man Chan, Hoi Lam Iris Or, Fong Yuen Chan, Hei Tung Yim, Vanessa R. Barrs, Potential therapeutic effects of GS-441524 and GC376 in cats with feline infectious peritonitis , Veterinary Evidence: Vol. 7 No. 1 (2022): The first issue of 2022
